Overview

Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

Status:
Completed
Trial end date:
2015-10-06
Target enrollment:
Participant gender:
Summary
A double-blind, randomized crossover study to assess the subjective abuse potential of intravenous remimazolam compared to midazolam and placebo in recreational CNS depressant users
Phase:
Phase 1
Details
Lead Sponsor:
Paion UK Ltd.
Collaborator:
PRA Health Sciences
Treatments:
Central Nervous System Depressants
Midazolam